148 related articles for article (PubMed ID: 36425152)
1. Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study.
Acar IH; Guner SI; Ak MA; Gocer M; Ozturk E; Atalay F; Sincan G; Yikilmaz AS; Ekinci O; Ince I; Gulturk E; Demir N; Dogan A; Ipek Y; Guvenc B
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022074. PubMed ID: 36425152
[TBL] [Abstract][Full Text] [Related]
2. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
3. "Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan".
Zaki A; Soomar SM; Khan DH; Shaharyar Sheikh H; Iftikhar R; Mir A; Aziz Z; Bano K; Naseer H; Chaudhry QU; Bokhari SWI; Shabbir-Moosajee M
PLoS One; 2022; 17(4):e0267139. PubMed ID: 35446898
[TBL] [Abstract][Full Text] [Related]
4. Frequency of hematologic malignancies in the population of Arica, Chile.
Pérez GB; Calaf GM; Villalba MTM; Prieto KS; Burgos FC
Oncol Lett; 2019 Nov; 18(5):5637-5643. PubMed ID: 31612068
[TBL] [Abstract][Full Text] [Related]
5. The outcome of COVID-19 in patients with hematological malignancy.
Tığlıoğlu P; Albayrak M; Tığlıoğlu M; Öztürk HBA; Aras MR; Sağlam B; Maral S
Memo; 2022; 15(1):83-89. PubMed ID: 34904019
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
Kim JS; Lee KH; Kim GE; Kim S; Yang JW; Li H; Hong SH; Ghayda RA; Kronbichler A; Koyanagi A; Jacob L; Shin JI; Smith L
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11926-11933. PubMed ID: 33275265
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
[TBL] [Abstract][Full Text] [Related]
8. Chest multidetector computed tomography imaging of COVID-19 pneumonia patients with hematologic malignancies.
El-Badrawy A; Elbadrawy N
Blood Res; 2022 Sep; 57(3):216-222. PubMed ID: 35920093
[TBL] [Abstract][Full Text] [Related]
9. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Rossi G; Salmanton-García J; Cattaneo C; Marchesi F; Dávila-Valls J; Martín-Pérez S; Itri F; López-García A; Glenthøj A; Gomes da Silva M; Besson C; Marchetti M; Weinbergerová B; Jaksic O; Jiménez M; Bilgin YM; Van Doesum J; Farina F; Žák P; Verga L; Collins GP; Bonuomo V; Van Praet J; Nucci M; Meers S; Espigado I; Fracchiolla NS; Valković T; Poulsen CB; Čolović N; Dragonetti G; Ledoux MP; Tascini C; Buquicchio C; Blennow O; Passamonti F; Machado M; Labrador J; Duarte RF; Schönlein M; Prezioso L; Falces-Romero I; Kulasekararaj A; Garcia-Vidal C; Fernández N; Abu-Zeinah G; Ormazabal-Vélez I; Adžić-Vukičević T; Piukovics K; Stoma I; Cuccaro A; Magliano G; Szotkowski T; González-López TJ; El-Ashwah S; Bergantim R; Sili U; Maertens J; Demirkan F; De Ramón C; Petzer V; Del Principe MI; Navrátil M; Dargenio M; Seval GC; Samarkos M; Ráčil Z; Pinczés LI; Lahmer T; Busca A; Méndez GA; Vena A; Biernat MM; Merelli M; Calbacho M; Barać A; Bavastro M; Limongelli A; Ilhan O; Wolf D; Çolak GM; García-Sanz R; Emarah Z; Mišković B; Gräfe SK; Mladenović M; Aiello TF; Núñez-Martín-Buitrago L; Nordlander A; Arellano E; Zambrotta GPM; Ammatuna E; Cabirta A; Sacchi MV; Nunes Rodrigues R; Hersby DS; Hanakova M; Rahimli L; Cordoba R; Cornely OA; Pagano L;
Int J Infect Dis; 2023 Dec; 137():98-110. PubMed ID: 37863310
[TBL] [Abstract][Full Text] [Related]
10. Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
Kalicińska E; Kuszczak B; Dębski J; Szukalski Ł; Wątek M; Strzała J; Rybka J; Czyż J; Lech-Marańda E; Zaucha J; Wróbel T
Support Care Cancer; 2021 Jan; 29(1):323-330. PubMed ID: 32361829
[TBL] [Abstract][Full Text] [Related]
11. Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma.
Akhtar S; Rauf MS; Al-Kofide A; Elshenawy MA; Mushtaq AH; Maghfoor I
Hered Cancer Clin Pract; 2021 Feb; 19(1):17. PubMed ID: 33563316
[TBL] [Abstract][Full Text] [Related]
12. Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Zappasodi P; Cattaneo C; Valeria Ferretti V; Mina R; José María Ferreri A; Merli F; Oberti M; Krampera M; Romano A; Zerbi C; Ferrari J; Cavo M; Salvini M; Bertù L; Stefano Fracchiolla N; Marchesi F; Massaia M; Marasco V; Cairoli R; Maria Scattolin A; Maria Vannucchi A; Gambacorti-Passerini C; Musto P; Gherlinzoni F; Cuneo A; Pinto A; Trentin L; Bocchia M; Galimberti S; Coviello E; Chiara Tisi M; Morotti A; Falini B; Turrini M; Tafuri A; Billio A; Gentile M; Massimo Lemoli R; Venditti A; Giovanni Della Porta M; Lanza F; Rigacci L; Tosi P; Mohamed S; Corso A; Luppi M; Giuliani N; Busca A; Pagano L; Bruno R; Antonio Grossi P; Corradini P; Passamonti F; Arcaini L;
Hematol Oncol; 2022 Dec; 40(5):846-856. PubMed ID: 35854643
[TBL] [Abstract][Full Text] [Related]
13. Hematologic malignancies and COVID-19 infection: A monocenter retrospective study.
Azhdari Tehrani H; Ramezaninejad S; Mardani M; Shokouhi S; Darnahal M; Hakamifard A
Health Sci Rep; 2022 May; 5(3):e638. PubMed ID: 35620550
[TBL] [Abstract][Full Text] [Related]
14. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
[TBL] [Abstract][Full Text] [Related]
15. Clinical In-Hospital Outcomes of Acute Myocardial Infarction in Patients With Hematological Malignancies.
Khan MZ; Baqi A; Patel K; Weinstock J; Franklin S; Kutalek S
Cureus; 2022 Jan; 14(1):e21627. PubMed ID: 35228975
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and outcome of COVID-19 in patients with hematological malignancies.
Piñana JL; Martino R; García-García I; Parody R; Morales MD; Benzo G; Gómez-Catalan I; Coll R; De La Fuente I; Luna A; Merchán B; Chinea A; de Miguel D; Serrano A; Pérez C; Diaz C; Lopez JL; Saez AJ; Bailen R; Zudaire T; Martínez D; Jurado M; Calbacho M; Vázquez L; Garcia-Cadenas I; Fox L; Pimentel AI; Bautista G; Nieto A; Fernandez P; Vallejo JC; Solano C; Valero M; Espigado I; Saldaña R; Sisinni L; Ribera JM; Jimenez MJ; Trabazo M; Gonzalez-Vicent M; Fernández N; Talarn C; Montoya MC; Cedillo A; Sureda A;
Exp Hematol Oncol; 2020; 9():21. PubMed ID: 32864192
[TBL] [Abstract][Full Text] [Related]
17. High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimination.
Ebid AIM; Hossam A; El Gammal MM; Soror S; Mangoud NOM; Mahmoud MA
J Chemother; 2022 Oct; 34(6):381-390. PubMed ID: 34895107
[TBL] [Abstract][Full Text] [Related]
18. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.
Borah P; Mirgh S; Sharma SK; Bansal S; Dixit A; Dolai TK; Lunkad S; Gupta N; Singh G; Jain A; Bansal D; Choudhary D; Khandelwal V; Doval D; Kumar M; Bhargava R; Chakrabarti A; Kalashetty M; Rauthan A; Kazi B; Mandal PK; Jeyaraman P; Naithani R;
Blood Cells Mol Dis; 2021 Mar; 87():102525. PubMed ID: 33338697
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis.
Rinaldi I; Pratama S; Wiyono L; Tandaju JR; Wardhana IL; Winston K
Front Oncol; 2022; 12():951215. PubMed ID: 36003763
[TBL] [Abstract][Full Text] [Related]
20. Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals.
Hossain MS; Iqbal MS; Khan MA; Rabbani MG; Khatun H; Munira S; Miah MM; Kabir AL; Islam N; Dipta TF; Rahman F; Mottalib A; Afrose S; Ara T; Biswas AR; Rahman M; Abedin AM; Rahman M; Yunus AB; Niessen LW; Sultana TA
BMC Cancer; 2014 Jun; 14():438. PubMed ID: 24929433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
